Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech Airgain Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh RXT Q1 2026 Earnings EPS Falls Short of Expectations Shares Slide 416 Annovis Bio Q1 2026 Earnings EPS Misses Estimates but Shares Rally on Pipeline Optimism ICHR Q1 2026 Earnings EPS Surpasses Expectations Stock Rises SCNX Q1 2026 Earnings Significant EPS Beat Despite Revenue Absence